STOCK TITAN

TVTX (NASDAQ: TVTX) shareholder plans sale of 7,175 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of common stock has filed a notice of intent to sell 7,175 shares of TVTX on the NASDAQ, with Morgan Stanley Smith Barney as broker. These shares were acquired on 01/31/2026 through restricted stock unit vesting as compensation from the issuer.

The filing notes that 89,472,327 common shares were outstanding and that, in the prior three months, Elizabeth E. Reed sold 10,000 common shares on 01/20/2026 for gross proceeds of 273,420. The seller represents they are not aware of any undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for TVTX disclose?

The Form 144 discloses an intended sale of 7,175 TVTX common shares on NASDAQ. The shares were acquired via restricted stock unit vesting on January 31, 2026 and will be sold through Morgan Stanley Smith Barney as the executing broker.

How many TVTX shares are planned to be sold under this Form 144?

The notice covers a planned sale of 7,175 TVTX common shares. These shares were recently acquired as compensation through restricted stock unit vesting and are scheduled for approximate sale on February 3, 2026 via NASDAQ.

How were the TVTX shares in this Form 144 acquired?

The 7,175 TVTX common shares were acquired on January 31, 2026 through restricted stock unit vesting from the issuer. The filing identifies the nature of the transaction as compensation, not a cash purchase, reflecting equity-based pay to the holder.

What prior TVTX share sales are reported in the last three months?

The filing reports that Elizabeth E. Reed sold 10,000 TVTX common shares on January 20, 2026. These sales generated gross proceeds of 273,420 and are disclosed to comply with aggregation requirements for sales over the preceding three-month period.

How many TVTX shares were outstanding when this Form 144 was filed?

The Form 144 lists 89,472,327 TVTX common shares as outstanding. This figure provides context for the relative size of the reported transaction and helps investors understand how the planned sale compares to the issuer’s overall equity base.

What representation does the TVTX seller make regarding inside information?

The seller represents that they do not know any material adverse information about TVTX’s current or prospective operations that has not been publicly disclosed. This statement is a standard Form 144 certification intended to address concerns about trading on nonpublic information.
Travere Therapeutics Inc

NASDAQ:TVTX

TVTX Rankings

TVTX Latest News

TVTX Latest SEC Filings

TVTX Stock Data

2.96B
82.79M
0.75%
117.25%
13.55%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO